Clinical value of 18 FDG PET/CT in screening for distant metastases in head and neck squamous cell carcinoma.
S E DeurvorstO S HoekstraJ A CastelijnsB I WitteC R LeemansRemco de BreePublished in: Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery (2018)
In head and neck squamous cell carcinoma patients with high-risk factors, 18 FDG PET/CT has a high negative predictive value for the detection of distant metastases and should be used in daily clinical practice, although the sensitivity is limited when long-term follow-up is used as reference standard.